- Home
- STRO
STRO
Sutro Biopharma Inc.
as 11-26-2025 3:40pm EST
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 94.9M | IPO Year: | 2018 |
| Target Price: | $1.97 | AVG Volume (30 days): | 782.2K |
| Analyst Decision: | Hold | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.59 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.52 - $3.01 | Next Earning Date: | 11-06-2025 |
| Revenue: | $105,646,000 | Revenue Growth: | -34.36% |
| Revenue Growth (this year): | 65.48% | Revenue Growth (next year): | -45.55% |
Latest Sutro Biopharma Inc. News
STRO Breaking Stock News: Dive into STRO Ticker-Specific Updates for Smart Investing
Argus Research
11 days ago
Daily – Vickers Top Insider Picks for 11/17/2025
Argus Research
14 days ago
Daily – Vickers Top Insider Picks for 11/14/2025
GlobeNewswire
15 days ago
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day
Zacks
21 days ago
Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates
GlobeNewswire
21 days ago
Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
22 days ago
Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025
Zacks
24 days ago
Syndax Pharmaceuticals (SNDX) Reports Q3 Loss, Lags Revenue Estimates
GlobeNewswire
25 days ago
Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference
Compare STRO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STRO Sutro Biopharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.